Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT03064867 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03064867
- Sponsor
- Molly Gallogly
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-26
- Primary completion
- 2022-08-12
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.